VamosVentures
Actively deployingLos Angeles · Seed
Fund manager profile
VamosVentures is a venture fund manager based in Los Angeles. SEC filings show 1 venture fund on record, most recently VamosVentures Fund II, L.P. ($100M offering) filed April 2026.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 1 of 1 portfolio companiesDigital Health ×1Enterprise Software ×1Healthtech ×1SaaS ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathYuvo Health provides software and business services to help community health centers operate more effectively within value-based care models. The company works with Federally Qualified Health Centers (FQHCs) to improve financial sustainability, care quality, and patient reach across community markets.
Digital HealthEnterprise SoftwareHealthtechSaaSNew York, US
Cesar Herrera(Chief Executive Officer and Co-Founder)Janel Sia(Chief Strategy Officer and Co-Founder)
Frequently asked questions
- What stage does VamosVentures invest at?
- VamosVentures invests at the Seed stage.
- Where is VamosVentures located?
- VamosVentures is headquartered in Los Angeles, US.
Similar investors
An early-stage venture capital firm focused on investing in Africa-based entrepreneurs building solutions for regional and global markets.
500 Global's Sustainable Growth practice designs and implements sovereign-aligned strategies that unlock resilient, inclusive, and sustainable economic growth across the Global Majority—Asia, Africa, Latin America, and the Middle East. The practice bridges public priorities and private capital through ecosystem development, blended finance, and localized innovation programs addressing health, agriculture, gender, climate, and education.
8VC is a technology investment firm focused on building and investing in ambitious companies across life sciences, healthcare, manufacturing, enterprise, logistics, and defense sectors, with particular emphasis on operational intelligence and data-driven decision-making.